Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/12/2008

PHARMANIAGA BERHAD

Financial Year End

31/12/2008
Quarter4
Quarterly report for the financial period ended31/12/2008
The figureshave been audited

Attachments

4Q2008.pdf
417 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2008

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/12/2008
31/12/2007
31/12/2008
31/12/2007
RM'000
RM'000
RM'000
RM'000
1Revenue
328,243
292,817
1,305,646
1,183,983
2Profit/(loss) before tax
24,496
23,572
90,599
77,898
3Profit/(loss) for the period
17,922
16,447
61,409
51,718
4Profit/(loss) attributable to ordinary equity holders of the parent
17,789
16,069
60,031
50,080
5Basic earnings/(loss) per share (sen)
16.63
15.02
56.12
46.82
6Proposed/Declared dividend per share (sen)
27.00
18.00
27.00
18.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.6300
3.2700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced27 Feb 2009  
CategoryFinancial Results
Reference NoPB-090226-36198